SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-043111
Filing Date
2010-02-26
Accepted
2010-02-26 17:08:20
Documents
8
Period of Report
2010-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16809
2 PLACEMENT AGENCY AGREEMENT dex11.htm EX-1.1 116052
3 FORM OF REGISTERED DIRECT WARRANT dex41.htm EX-4.1 52201
4 OPINION OF WYRICK ROBBINS YATES & PONTON LLP dex51.htm EX-5.1 8048
5 FORM OF SUBSCRIPTION AGREMENT dex1015.htm EX-10.15 60028
6 PRESS RELEASE dex991.htm EX-99.1 8089
7 GRAPHIC g19653g50g83.jpg GRAPHIC 13108
8 GRAPHIC g19653g80c40.jpg GRAPHIC 9878
  Complete submission text file 0001193125-10-043111.txt   294806
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 10640487
SIC: 2836 Biological Products, (No Diagnostic Substances)